Sprucegrove Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Sprucegrove Investment Management's BIIB Position: Q3 2025 in Review
Sprucegrove Investment Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 13,310 shares — an estimated $1.67M sold.
Sprucegrove Investment Management first reported a position in BIIB in Q1 2021 and held it in 18 quarters. The position peaked at $77.6M in Q4 2021. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- Sprucegrove Investment Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- Sprucegrove Investment Management sold 13,310 Biogen shares in Q3 2025, an estimated $1.67M.
- Sprucegrove Investment Management first reported a position in Biogen in Q1 2021 and held it in 18 quarters.
- Sprucegrove Investment Management's Biogen position peaked at $77.6M in Q4 2021.
- 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on Sprucegrove Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.